Insmed (INSM) Misses Q2 EPS by 70c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $104.82 -4.11%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q2 EPS of ($1.94), $0.70 worse than the analyst estimate of ($1.24). Revenue for the quarter came in at $90.3 million versus the consensus estimate of $87.95 million.
GUIDANCE:
Insmed sees FY2024 revenue of $340-360 million, versus the consensus of $353.2 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Downgrades PayPal (PYPL) to Hold
- Fiserv Inc (FISV) Tops Q3 EPS by 3c ; Offers Guidance
- Anthropic: introduce Flashprove
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
